{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:44:36Z","timestamp":1788223476774,"version":"build-2803163510"},"reference-count":344,"publisher":"Baishideng Publishing Group Inc.","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2021,7,14]]},"DOI":"10.3748\/wjg.v27.i26.4104","type":"journal-article","created":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T13:17:20Z","timestamp":1626009440000},"page":"4104-4142","source":"Crossref","is-referenced-by-count":40,"title":["Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges"],"prefix":"10.3748","volume":"27","author":[{"given":"Hsuan","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Cheng","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzung-Hai","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000428"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200939"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.061"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00774.x"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp331"},{"key":"B6","unstructured":"Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol 2010; 23: 253-262"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5520(05)70177-x"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.363"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr464"},{"key":"B10","doi-asserted-by":"crossref","unstructured":"Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-99","DOI":"10.1016\/S0140-6736(99)06154-1"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(16)30554-5"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.23.2823"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015677"},{"key":"B14","doi-asserted-by":"crossref","unstructured":"Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol 1998; 18: 89-95","DOI":"10.1159\/000013314"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034026"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-016-0463-x"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018060609"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22397"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.04.038"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.07.015"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23529"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.05.089"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.107"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000343852"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.014"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.10.007"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hys100"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000186770"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.16"},{"key":"B31","doi-asserted-by":"crossref","unstructured":"Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995; 154: 882-892","DOI":"10.4049\/jimmunol.154.2.882"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010263"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10096"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2001.01036.x"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.4.502"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn266"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V131204"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1283-4"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31827743b4"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12199"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34613"},{"key":"B42","unstructured":"Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol 2002; 15: 463-468"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s0300-483x(02)00612-1"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00450.x"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000315247"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609498104"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.24.2023"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140485"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.007"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09011010"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2016.04.007"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2016.05.008"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010473"},{"key":"B54","unstructured":"composition of alcoholic beverages, additives and contaminants. IARC Monogr Eval Carcinog Risks Hum 1988; 44: 71-99"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23845"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24066"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30036"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.016"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1159\/000323740"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1564794"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v5.i12.685"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"B63","unstructured":"Cooney TG, Bauer DC, Knauer CM. Portal hypertension associated with hepatocellular carcinoma with cirrhosis. Am J Gastroenterol 1980; 74: 436-438"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1159\/000078812"},{"key":"B65","unstructured":"D'Antonio A, Caleo A, Caleo O, Addesso M, Boscaino A. Hepatocellular carcinoma metastatic to the kidney mimicking renal oncocytoma. Hepatobiliary Pancreat Dis Int 2010; 9: 550-552"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2016.10.009"},{"key":"B67","doi-asserted-by":"crossref","unstructured":"Thomas DM, Nasim MM, Gullick WJ, Alison MR. Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract. Gut 1992; 33: 628-631","DOI":"10.1136\/gut.33.5.628"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0099"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3339\/jkspn.2017.21.1.21"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/08860220500531005"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1993.tb00651.x"},{"key":"B72","unstructured":"Leone N, Debernardi-Venon W, Marzano A, Massari M, Rizzetto M. Hypercalcaemia secondary to hepatocellular carcinoma. Ital J Gastroenterol Hepatol 1999; 31: 604-606"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2018.05.17"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-41088-2_32"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-010-9328-y"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2016.09.032"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2174\/138920012799320446"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg143"},{"key":"B79","unstructured":"Yamamoto S, Konishi Y, Matsuda T, Murai T, Shibata MA, Matsui-Yuasa I, Otani S, Kuroda K, Endo G, Fukushima S. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344\/DuCrj rats after pretreatment with five carcinogens. Cancer Res 1995; 55: 1271-1276"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/15287390490486806"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9297259"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfn120"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-010-9351-z"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2004.01.006"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-015-1172-8"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2005.05.016"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-2952(01)00716-x"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.21608\/ejcm.2015.714"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9074861"},{"key":"B90","unstructured":"Kew MC. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointestin Liver Dis 2013; 22: 305-310"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7238"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.1.81"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03380-2"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(01)06576-x"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2006.08.004"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan6446"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1685516"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602333"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2001.iep0082-0077-x"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(81)90585-7"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90770-8"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0274"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1154-4"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1159\/000077065"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i11.1752"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1084-9"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.455"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0666"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.065"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.12.007"},{"key":"B111","doi-asserted-by":"crossref","unstructured":"Moore MA, Park CB, Tsuda H. Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev 1998; 7: 89-107","DOI":"10.1097\/00008469-199808000-00014"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.94944"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.12.052"},{"key":"B114","doi-asserted-by":"crossref","unstructured":"Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164-176","DOI":"10.2337\/diacare.28.1.164"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i12.1436"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1456_17"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00929.x"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.024935"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23995"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.03.020"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.01.013"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12964"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30625"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0260155"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1159\/000313363"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.034"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27699"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112528"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i19.3396"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(00)70368-4"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1078\/0940-2993-00309"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1023\/b:ddas.0000043369.88701.5b"},{"key":"B134","unstructured":"Yoshiji H, Noguchi R, Kuriyama S, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Uemura M, Fukui H. Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats. Anticancer Res 2005; 25: 3335-3340"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17127"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12062"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2020.11.007"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007122"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.8962"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7401"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1097\/01.SLA.0000059988.22416.F2"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-2574.2012.00594.x"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9799-9"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100134"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-013-2390-3"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-2574.2012.00452.x"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-018-4698-3"},{"key":"B152","doi-asserted-by":"crossref","unstructured":"Cheng SB, Wu CC, Shu KH, Ho WL, Chen JT, Yeh DC, Liu TJ, P'eng FK. Liver resection for hepatocellular carcinoma in patients with end-stage renal failure. J Surg Oncol 2001; 78: 241-6; discussion 246","DOI":"10.1002\/jso.1160"},{"key":"B153","doi-asserted-by":"crossref","unstructured":"Yeh CN, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol 2005; 11: 2067-2071","DOI":"10.3748\/wjg.v11.i14.20"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-013-2137-z"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22365"},{"key":"B156","doi-asserted-by":"crossref","unstructured":"Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006; 5: 77-85","DOI":"10.1016\/S1665-2681(19)32022-8"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.04.003"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1159\/000185938"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.09.096"},{"key":"B160","unstructured":"Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998; 12: 123-129"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.05.053"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2376-8"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00004.x"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.08.059"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21682"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23522"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2018.5431\/2017"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25468"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(92)90053-s"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp112"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021744"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500050513"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199807150-00010"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199612270-00018"},{"key":"B175","unstructured":"Lafayette RA, Par\u00e9 G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 1997; 48: 159-164"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1590\/s1679-45082012000100012"},{"key":"B177","doi-asserted-by":"crossref","unstructured":"Aguilera V, Ferrer I, Berenguer M, Rivera J, Rub\u00edn \u00c1, Moya \u00c1, Pareja E, S\u00e1nchez J, Prieto M, Mir J. Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation. Ann Hepatol 2013; 12: 274-281","DOI":"10.1016\/S1665-2681(19)31366-3"},{"key":"B178","unstructured":"Kliem V, Ringe B, Frei U, Pichlmayr R. Single-center experience of combined liver and kidney transplantation. Clin Transplant 1995; 9: 39-44"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.07.008"},{"key":"B180","unstructured":"Margreiter R, Steurer W, Spechtenhauser B, K\u00f6nigsrainer A. Kidney transplantation together with another solid organ from the same donor--a single-center progress report. Clin Nephrol 2000; 53: suppl 38-suppl 43"},{"key":"B181","unstructured":"Zhu XF, He XS, Chen GH, Chen LZ, Wang CX, Huang JF. Combined liver and kidney transplantation in Guangzhou, China. Hepatobiliary Pancreat Dis Int 2007; 6: 585-589"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2018.05.012"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000048"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001515"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2262012198"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.8691"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1737-4"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200109000-00011"},{"key":"B189","unstructured":"Tsui SL, Lee AK, Lui SK, Poon RT, Fan ST. Acute intraoperative hemolysis and hemoglobinuria during radiofrequency ablation of hepatocellular carcinoma. Hepatogastroenterology 2003; 50: 526-529"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2009.08.008"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(99)00043-4"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s004230050263"},{"key":"B193","unstructured":"Fukumori K, Shakado S, Makihata T, Takemoto R, Fukuizumi K, Miyahara T, Yasumori K, Muranaka T, Watanabe J, Saitsu H, Sakai H, Sata M. [A case of chronic renal failure caused hyperkalemia following percutaneous radiofrequency ablation therapy for hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi 2003; 100: 702-706"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1192"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.08.2236"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13780"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200209000-00015"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i8.1020"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-4893-x"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02128.x"},{"key":"B201","unstructured":"Zhou C, Wang R, Ding Y, Du L, Hou C, Lu D, Hao L, Lv W. Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma. Int J Clin Exp Pathol 2014; 7: 2579-2586"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.00911.x"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021833"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.2174\/1389203717666160909124305"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.151984"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181c88235"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017007"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2014.08.024"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1259\/bjro.20190004"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.103"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-871200"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.114428"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2130"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17423"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.110106.214058"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm311"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/710216"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.07.020"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.5414\/cpp47061"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12156"},{"key":"B222","unstructured":"Bayer HealthCare Pharmaceuticals Inc. NEXAVAR (sorafenib) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021923s024lblrpl.pdf"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.10946.x"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00264-x"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13243"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13294"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1909"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017588"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1159\/000494080"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1074-3"},{"key":"B232","unstructured":"Eisai Inc. LENVIMA (lenvatinib) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/206947s018lbl.pdf"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32453-9"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0707-5"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.04.010"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70364-9"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61900-X"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X15580743"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw392.37"},{"key":"B240","unstructured":"Bayer HealthCare Pharmaceuticals Inc. STIVARGA (regorafenib) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/203085s013lbl.pdf"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2017.03.013"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1717002"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.714"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01272-y"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1159\/000491387"},{"key":"B246","unstructured":"Exelixis Inc. COMETRIQ (cabozantinib) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/203756s009lbl.pdf"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00050-9"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12780"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.4115"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30937-9"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016236"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1159\/000437253"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1194-9"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-03876-5"},{"key":"B255","unstructured":"Eli Lilly and Company. CYRAMZA (ramucirumab) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125477s037lbl.pdf"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.05.005"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181b2362f"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010020167"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18190"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.05.015"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn168"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1177\/1078155218774895"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212466421"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H635"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv139"},{"key":"B267","unstructured":"Genentech Inc. AVASTIN (bevacizumab) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125085s337lbl.pdf"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl664"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102859"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.174"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.007"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.2174\/1872213x09666150131141953"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29418"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02166"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000419"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3452762"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0053-3"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.7421"},{"key":"B280","unstructured":"Genentech Inc. TECENTRIQ (atezolizumab) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761034s020lbl.pdf"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30351-6"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01307"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy100"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1159\/000455014"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0478-8"},{"key":"B286","unstructured":"Merck Sharp & Dohme Corp. KEYTRUDA (pembrolizumab) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125514s088lbl.pdf"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS4147"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0408-2"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1848"},{"key":"B291","unstructured":"Bristol-Myers Squibb Company. OPDIVO (nivolumab) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/125527s000lbl.pdf"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4564"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.04.008"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2015.11.001"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0904283"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9794-7"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.06.011"},{"key":"B298","unstructured":"Bristol-Myers Squibb Company. YERVOY (ipilimumab) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125377s119lbl.pdf"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2016.1229790"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.601661"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1007\/82_2010_84"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100643"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1126\/science.1148536"},{"key":"B304","doi-asserted-by":"publisher","DOI":"10.1038\/415536a"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700616"},{"key":"B306","doi-asserted-by":"crossref","unstructured":"Pfeffer CR. Assessment of suicidal children and adolescents. Psychiatr Clin North Am 1989; 12: 861-872","DOI":"10.1016\/S0193-953X(18)30401-5"},{"key":"B307","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25777"},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0667-4"},{"key":"B309","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0140-4"},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090859"},{"key":"B311","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.02.007"},{"key":"B312","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.11.024"},{"key":"B313","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3486-7"},{"key":"B314","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13440"},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9647-8"},{"key":"B316","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.009"},{"key":"B317","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00013"},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)91995-x"},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.039"},{"key":"B320","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31289"},{"key":"B321","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26180"},{"key":"B322","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033364"},{"key":"B323","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30249-1"},{"key":"B324","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.09.025"},{"key":"B325","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29320"},{"key":"B326","doi-asserted-by":"crossref","unstructured":"Pellicelli AM, Vignally P, Messina V, Izzi A, Mazzoni E, Barlattani A, Bacca D, Romano M, Mecenate F, Stroffolini T, Furlan C, Picardi A, Gentilucci UV, Gulminetti R, Bonaventura ME, Villani R, D'Ambrosio C, Paffetti A, Mastropietro C, Marignani M, Fondacaro L, Cerasari G, Andreoli A, Barbarini G. Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinoma. Ann Hepatol 2014; 13: 376-385","DOI":"10.1016\/S1665-2681(19)30844-0"},{"key":"B327","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.145"},{"key":"B328","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306409"},{"key":"B329","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00833-06"},{"key":"B330","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.05.035"},{"key":"B331","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.229-235.2001"},{"key":"B332","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.12.3209"},{"key":"B333","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13399"},{"key":"B334","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.02.012"},{"key":"B335","unstructured":"Bristol-Myers Squibb Company. BARACLUDE (entecavir) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021797s023, 021798s024lbl.pdf"},{"key":"B336","unstructured":"Gilead Sciences, Inc. VIREAD (tenofovir disoproxil fumarate) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021356s058,022577s014lbl.pdf"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-015-0070-1"},{"key":"B338","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066223"},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu617"},{"key":"B340","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13313"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00128-15"},{"key":"B342","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.039"},{"key":"B343","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2770"},{"key":"B344","unstructured":"Gilead Sciences, Inc. VEMLIDY (tenofovir alafenamide) [package insert]. U.S. Food and Drug Administration website. [cited 12 March 2021]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/Label\/2021\/208464s012 Lbl.pdf"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v27\/i26\/4104.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T17:51:20Z","timestamp":1672768280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v27\/i26\/4104.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":344,"journal-issue":{"issue":"26"},"URL":"https:\/\/doi.org\/10.3748\/wjg.v27.i26.4104","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}